Imagine a surgeon operating a tiny catheter inside a patient's blood vessel from a different room, or even a different city. This system acts like a high-tech remote control that lets the doctor feel the resistance of the vessel walls as if they were right there. It removes the need for medical staff to stand under dangerous X-ray machines during the procedure.
Medical staff are exposed to harmful X-ray radiation during endovascular procedures, and patients in remote areas often face dangerous transport times to reach specialized surgeons.
The Sentante robotic system, a tele-operated device that provides haptic force feedback and is compatible with standard endovascular tools.
If you are a hospital dealing with a shortage of experienced surgeons on-site — this project developed the Sentante robot that allows doctors to perform full interventions from a different room or hospital. This optimizes 24/7 service and helps retain expert staff.
If you are a manufacturer dealing with the need for robotic compatibility for your catheters — this project developed a system with universal compatibility with marketed endovascular devices. This allows your existing tools to be used in robotic surgeries without redesign.
If you are a health network dealing with the risk of transporting critical patients between local and central hospitals — this project developed a tele-operated system that brings the surgeon's expertise to the patient remotely. This improves treatment access in urgent cases.
Based on available project data, specific pricing and cost details are not provided.
Yes, the system is designed for fast implementation into routine clinical workflows with almost no additional training for doctors, facilitating scale across hospitals.
The project has submitted new patent applications to protect relevant IP and is pursuing a CE mark for commercialization in EU and US markets.
The system is moving toward receiving a CE mark following the completion of the project and clinical trials.
It features universal compatibility with marketed endovascular devices, meaning it works with standard off-the-shelf tools.
The project is led by a single Lithuanian SME, UAB Inovatyvi Medicina, representing a 100% industry-led consortium. This lean structure suggests a highly focused commercial drive, moving directly from prototype to clinical validation without the overhead of academic partners.
Contact UAB Inovatyvi Medicina in Lithuania
Contact us to explore licensing opportunities for the Sentante robotic system.
